D. Groheux, E. Hindié, M. Delord, S. Giacchetti, A. Hamy et al., Prognostic Impact of 18FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer, JNCI Journal of the National Cancer Institute, vol.104, issue.24, pp.1879-87, 2012.
DOI : 10.1093/jnci/djs451

A. Cochet, I. Dygai-cochet, J. Riedinger, O. Humbert, A. Berriolo-riedinger et al., 18F-FDG PET/CT provides powerful prognostic stratification in the primary staging of large breast cancer when compared with conventional explorations, European Journal of Nuclear Medicine and Molecular Imaging, vol.104, issue.24, pp.428-465, 2014.
DOI : 10.1007/s00259-013-2595-4
URL : https://hal.archives-ouvertes.fr/hal-00930891

D. Groheux, S. Giacchetti, M. Espie, D. Rubello, J. Moretti et al., Early monitoring of response to neoadjuvant chemotherapy in breast cancer with 18F-FDG PET/CT: defining a clinical aim, European Journal of Nuclear Medicine and Molecular Imaging, vol.35, issue.3, pp.419-444, 2011.
DOI : 10.1007/s00259-010-1660-5

D. Azambuja, E. Holmes, A. Piccart-gebhart, M. Holmes, E. et al., Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response, The Lancet Oncology, vol.15, issue.10, pp.1137-1183, 2014.
DOI : 10.1016/S1470-2045(14)70320-1

D. Groheux, S. Giacchetti, J. Moretti, R. Porcher, M. Espie et al., Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.16, issue.7, pp.426-461, 2011.
DOI : 10.1007/s00259-010-1640-9

B. Koolen, V. Peeters, M. Wesseling, J. Lips, E. Vogel et al., Association of primary tumour FDG uptake with clinical, histopathological and molecular characteristics in breast cancer patients scheduled for neoadjuvant chemotherapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.17, issue.12, pp.1830-1838, 2012.
DOI : 10.1007/s00259-012-2211-z

M. Oshida, K. Uno, M. Suzuki, T. Nagashima, H. Hashimoto et al., Predicting the prognoses of breast carcinoma patients with positron emission tomography using 2-deoxy-2-fluoro[18F]-D-glucose, Cancer, vol.88, issue.11, pp.2227-2261, 1998.
DOI : 10.1002/(SICI)1097-0142(19980601)82:11<2227::AID-CNCR18>3.0.CO;2-W

M. Soussan, F. Orlhac, M. Boubaya, L. Zelek, M. Ziol et al., Relationship between Tumor Heterogeneity Measured on FDG-PET/CT and Pathological Prognostic Factors in Invasive Breast Cancer, PLoS ONE, vol.112, issue.4, p.94017, 2014.
DOI : 10.1371/journal.pone.0094017.s001

S. Son, D. Kim, C. Hong, C. Kim, S. Jeong et al., Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast, BMC Cancer, vol.27, issue.1, p.585, 2014.
DOI : 10.1200/JCO.2007.13.7083

M. Hatt, C. Le-rest, C. Descourt, P. Dekker, A. et al., Accurate Automatic Delineation of Heterogeneous Functional Volumes in Positron Emission Tomography for Oncology Applications, International Journal of Radiation Oncology*Biology*Physics, vol.77, issue.1, pp.301-309, 2010.
DOI : 10.1016/j.ijrobp.2009.08.018
URL : https://hal.archives-ouvertes.fr/inserm-00537776

M. Hatt, C. Le-rest, C. Turzo, A. Roux, C. Visvikis et al., A Fuzzy Locally Adaptive Bayesian Segmentation Approach for Volume Determination in PET, IEEE Transactions on Medical Imaging, vol.28, issue.6, pp.881-93, 2009.
DOI : 10.1109/TMI.2008.2012036
URL : https://hal.archives-ouvertes.fr/inserm-00372910

M. Hatt, D. Groheux, A. Martineau, M. Espié, E. Hindié et al., Comparison Between 18F-FDG PET Image-Derived Indices for Early Prediction of Response to Neoadjuvant Chemotherapy in Breast Cancer, Journal of Nuclear Medicine, vol.54, issue.3, pp.341-350, 2013.
DOI : 10.2967/jnumed.112.108837
URL : https://hal.archives-ouvertes.fr/hal-00748923

F. Van-velden, P. Cheebsumon, M. Yaqub, E. Smit, O. Hoekstra et al., Evaluation of a cumulative SUV-volume histogram method for parameterizing heterogeneous intratumoural FDG uptake in non-small cell lung cancer PET studies, European Journal of Nuclear Medicine and Molecular Imaging, vol.72, issue.9, pp.1636-1683, 2011.
DOI : 10.1007/s00259-011-1845-6

F. Tixier, M. Hatt, L. Rest, C. , L. Pogam et al., Reproducibility of Tumor Uptake Heterogeneity Characterization Through Textural Feature Analysis in 18F-FDG PET, Journal of Nuclear Medicine, vol.53, issue.5, pp.693-700, 2012.
DOI : 10.2967/jnumed.111.099127
URL : https://hal.archives-ouvertes.fr/inserm-00721377

M. Hatt, F. Tixier, C. Le-rest, C. Pradier, O. Visvikis et al., Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.44, issue.Spec No 1, pp.1662-71, 2013.
DOI : 10.1007/s00259-013-2486-8

M. Hatt, M. Majdoub, M. Vallières, F. Tixier, L. Rest et al., 18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi-Cancer Site Patient Cohort, Journal of Nuclear Medicine, vol.56, issue.1, pp.38-44, 2015.
DOI : 10.2967/jnumed.114.144055

P. Galavis, C. Hollensen, N. Jallow, B. Paliwal, and R. Jeraj, Variability of textural features in FDG PET images due to different acquisition modes and reconstruction parameters, Acta Oncologica, vol.45, issue.9, pp.1012-1018, 2010.
DOI : 10.1016/j.patcog.2008.08.011

F. Brooks and P. Grigsby, The Effect of Small Tumor Volumes on Studies of Intratumoral Heterogeneity of Tracer Uptake, Journal of Nuclear Medicine, vol.55, issue.1, pp.37-42, 2014.
DOI : 10.2967/jnumed.112.116715

Y. Benjamini and Y. Hochberg, Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing, J R Stat. Soc B, vol.57, pp.289-300, 1995.

E. Naqa, I. Grigsby, P. Apte, A. Kidd, E. Donnelly et al., Exploring feature-based approaches in PET images for predicting cancer treatment outcomes, Pattern Recognition, vol.42, issue.6, pp.1162-71, 2009.
DOI : 10.1016/j.patcog.2008.08.011

H. Aerts, E. Velazquez, R. Leijenaar, C. Parmar, P. Grossmann et al., Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach, Nat. Commun, vol.5, p.4006, 2014.

P. Lambin, E. Rios-velazquez, R. Leijenaar, S. Carvalho, R. Van-stiphout et al., Radiomics: Extracting more information from medical images using advanced feature analysis, European Journal of Cancer, vol.48, issue.4, pp.441-447, 2012.
DOI : 10.1016/j.ejca.2011.11.036

F. Tixier, M. Hatt, C. Valla, V. Fleury, C. Lamour et al., Visual Versus Quantitative Assessment of Intratumor 18F-FDG PET Uptake Heterogeneity: Prognostic Value in Non-Small Cell Lung Cancer, Journal of Nuclear Medicine, vol.55, issue.8, pp.1235-1276, 2014.
DOI : 10.2967/jnumed.113.133389
URL : https://hal.archives-ouvertes.fr/inserm-01074715

G. Cook, C. Yip, M. Siddique, V. Goh, S. Chicklore et al., Are Pretreatment 18F-FDG PET Tumor Textural Features in Non-Small Cell Lung Cancer Associated with Response and Survival After Chemoradiotherapy?, Journal of Nuclear Medicine, vol.54, issue.1, pp.19-26, 2013.
DOI : 10.2967/jnumed.112.107375

D. Groheux, S. Giacchetti, M. Delord, A. De-roquancourt, P. Merlet et al., Prognostic impact of 18F-FDG PET/CT staging and of pathological response to neoadjuvant chemotherapy in triple-negative breast cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.266, issue.3, pp.377-85, 2015.
DOI : 10.1007/s00259-014-2941-1

F. Tixier, A. Groves, V. Goh, M. Hatt, P. Ingrand et al., Correlation of Intra-Tumor 18F-FDG Uptake Heterogeneity Indices with Perfusion CT Derived Parameters in Colorectal Cancer, PLoS ONE, vol.19, issue.1, p.99567, 2014.
DOI : 10.1371/journal.pone.0099567.t003

S. Basu, T. Kwee, R. Gatenby, B. Saboury, D. Torigian et al., Evolving role of molecular imaging with PET in detecting and characterizing heterogeneity of cancer tissue at the primary and metastatic sites, a plausible explanation for failed attempts to cure malignant disorders, European Journal of Nuclear Medicine and Molecular Imaging, vol.37, issue.9, pp.987-91, 2011.
DOI : 10.1007/s00259-011-1787-z

J. Rajendran, D. Schwartz, O. Sullivan, J. Peterson, L. Ng et al., Tumor Hypoxia Imaging with [F-18] Fluoromisonidazole Positron Emission Tomography in Head and Neck Cancer, Clinical Cancer Research, vol.12, issue.18, pp.5435-5476, 2006.
DOI : 10.1158/1078-0432.CCR-05-1773

M. Kunkel, T. Reichert, P. Benz, H. Lehr, J. Jeong et al., Overexpression of Glut-1 and increased glucose metabolism in tumors are associated with a poor prognosis in patients with oral squamous cell carcinoma, Cancer, vol.28, issue.4, pp.1015-1039, 2003.
DOI : 10.1002/cncr.11159

J. Alvarez, G. Belka, T. Pan, C. Chen, E. Blankemeyer et al., Oncogene Pathway Activation in Mammary Tumors Dictates FDG-PET Uptake, Cancer Research, vol.74, issue.24, pp.7583-98, 2014.
DOI : 10.1158/0008-5472.CAN-14-1235

M. Straver, E. Rutgers, S. Rodenhuis, S. Linn, C. Loo et al., The Relevance of Breast Cancer Subtypes in the Outcome of Neoadjuvant Chemotherapy, Annals of Surgical Oncology, vol.197, issue.3
DOI : 10.1245/s10434-010-1008-1

L. Esserman, D. Berry, A. Demichele, L. Carey, S. Davis et al., Pathologic Complete Response Predicts Recurrence-Free Survival More Effectively by Cancer Subset: Results From the I-SPY 1 TRIAL???CALGB 150007/150012, ACRIN 6657, Journal of Clinical Oncology, vol.30, issue.26, pp.3242-3251, 2012.
DOI : 10.1200/JCO.2011.39.2779

S. Yip, K. Mccall, M. Aristophanous, A. Chen, H. Aerts et al., Comparison of Texture Features Derived from Static and Respiratory-Gated PET Images in Non-Small Cell Lung Cancer, PLoS ONE, vol.53, issue.12, p.115510, 2014.
DOI : 10.1371/journal.pone.0115510.t003

B. Koolen, S. Vidal-sicart, B. Baviera, J. , V. Olmos et al., Evaluating heterogeneity of primary tumor 18F-FDG uptake in breast cancer with a dedicated breast PET (MAMMI), Nuclear Medicine Communications, vol.35, issue.5, pp.446-52, 2014.
DOI : 10.1097/MNM.0000000000000072

J. Kalinyak, W. Berg, K. Schilling, K. Madsen, D. Narayanan et al., Breast cancer detection using high-resolution breast PET compared to whole-body PET or PET/CT, European Journal of Nuclear Medicine and Molecular Imaging, vol.28, issue.6, pp.260-75, 2014.
DOI : 10.1007/s00259-013-2553-1

O. Humbert, A. Berriolo-riedinger, A. Cochet, M. Gauthier, C. Charon-barra et al., Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer
URL : https://hal.archives-ouvertes.fr/hal-00930893

H. Linden and F. Dehdashti, Novel Methods and Tracers for Breast Cancer Imaging, Seminars in Nuclear Medicine, vol.43, issue.4, pp.324-333, 2013.
DOI : 10.1053/j.semnuclmed.2013.02.003